Iron Sucrose is Preferred Over Iron Dextran
Iron sucrose should be your first-line intravenous iron preparation over iron dextran due to its superior safety profile, particularly the significantly lower risk of serious anaphylactic reactions. While both formulations are effective at correcting iron deficiency anemia, the critical difference lies in patient safety and mortality risk.
Safety Profile: The Decisive Factor
The evidence consistently demonstrates that iron dextran carries unacceptable safety risks compared to iron sucrose:
Iron dextran requires a mandatory test dose due to documented risk of IgE-mediated anaphylactic reactions from preformed dextran antibodies, with serious reactions occurring in 0.6-0.7% of patients and 31 reported fatalities between 1976-1996 1
Iron dextran carries an FDA black box warning for anaphylactic-type reactions, including fatalities 2. The FDA label explicitly states that "fatal reactions have followed the test dose of iron dextran and have also occurred in situations where the test dose was tolerated" 2
Iron sucrose does not require a test dose and has a markedly better safety profile with very few serious adverse reactions documented 3, 1
Multiple guidelines explicitly state that iron dextran should only be used "in extraordinary circumstances" 4 and that "iron dextran still remains on the market despite a higher risk of hypersensitivity reactions than with iron sucrose" 5
Clinical Efficacy: Essentially Equivalent
From an efficacy standpoint, both preparations achieve similar outcomes:
Hemoglobin response at 12 weeks is comparable between iron dextran and iron sucrose 1
A head-to-head randomized trial in pre-dialysis CKD patients found no significant difference in the proportion achieving ≥1.0 g/dL hemoglobin rise: 21.9% with low molecular weight iron dextran versus 32.4% with iron sucrose (P = 0.23) 6
Both formulations effectively correct iron deficiency and replenish iron stores 6
Practical Considerations
Dosing differences:
- Iron sucrose: Maximum 200-300 mg per infusion over 10 minutes, requiring multiple visits for complete repletion 7, 1, 7
- Low molecular weight iron dextran: Can deliver up to 1000 mg in a single 6-hour infusion 1
Cost considerations:
- Iron dextran is significantly cheaper (£79.70 per gram) compared to iron sucrose (£70.80 per gram) 1
- However, the cost savings are negated by the need for resuscitation equipment, trained personnel, mandatory test doses, and longer infusion times
Current Guideline Consensus
The most recent 2024 AGA guideline states: "Large studies have shown that all IV iron formulations are associated with adverse effects, so from a safety standpoint no one product is preferred" 8. However, this statement applies to newer formulations (ferric carboxymaltose, ferric derisomaltose, ferumoxytol) and specifically notes these are preferred because they allow 1-2 infusion replacement schedules.
The 2018 pediatric guideline explicitly states: "More recently introduced iron compounds, e.g. iron sucrose, iron gluconate, iron carboxymaltose are considered to have less adverse effects than iron dextran" 3.
Critical Caveats
When iron dextran might be considered:
- Only low molecular weight iron dextran (not high molecular weight, which is off the market)
- When single-dose total replacement is absolutely necessary and newer formulations (ferric carboxymaltose, ferric derisomaltose) are unavailable
- Must have immediate access to resuscitation equipment and personnel trained in anaphylaxis management 2
- Increased risk in patients with drug allergies, multiple drug allergies, or those on ACE inhibitors 2
Optimal modern approach: If you need single-dose iron replacement, choose ferric carboxymaltose (1000 mg in 15 minutes) or ferric derisomaltose over either iron dextran or iron sucrose 8, 9. These newer formulations combine the convenience of single-dose administration with the safety profile of iron sucrose.
Bottom Line Algorithm
- First choice: Iron sucrose (if multiple visits acceptable) or newer formulations like ferric carboxymaltose (if single-dose preferred)
- Avoid: Iron dextran except in extraordinary circumstances where no alternatives exist
- Never use: High molecular weight iron dextran (no longer available)
- Always have: Resuscitation equipment available regardless of formulation chosen 1
The preponderance of evidence, including FDA warnings, documented fatalities, and guideline recommendations, makes iron sucrose the safer choice when comparing these two specific formulations 3, 1, 2, 5.